Compounds > tenidap
Page last updated: 2024-08-24

tenidap and Disease Models, Animal

tenidap has been researched along with Disease Models, Animal in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (77.78)18.2507
2000's0 (0.00)29.6817
2010's1 (11.11)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Hao, Y; Hong, Z; Wu, X; Xu, L; Yu, P; Zhu, G1
Breedveld, F1
Aleo, MD; Giebisch, G; Lopez-Anaya, A; Sanders, MJ; Walsh, AH; Wang, T1
Caron, JP; Fernandes, JC; Jovanovic, D; Martel-Pelletier, J; Mineau, F; Otterness, IG; Pelletier, JP; Tardif, G1
Caron, JP; Fernandes, JC; Jovanovic, D; Martel-Pelletier, J; Pelletier, JP; Ricketts, T1
Golub, LM; Greenwald, RA; Leng, W; Moak, SA; Wohl, GR; Zernicke, RF1
Bliven, ML; Eskra, JD; Otterness, IG1
Egido, J; Gutierrez, S; Hernandez, P; Herrero-Beaumont, G; Lopez-Armada, MJ; Martinez, J; Miguelez, R; Palacios, I; Sanchez-Pernaute, O1

Reviews

1 review(s) available for tenidap and Disease Models, Animal

ArticleYear
Tenidap: a novel cytokine-modulating antirheumatic drug for the treatment of rheumatoid arthritis.
    Scandinavian journal of rheumatology. Supplement, 1994, Volume: 100

    Topics: Acute-Phase Proteins; Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials, Phase III as Topic; Consumer Product Safety; Cytokines; Disease Models, Animal; Female; Humans; Indoles; Male; Middle Aged; Oxindoles; Rats; Treatment Outcome

1994

Other Studies

8 other study(ies) available for tenidap and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Tenidap, an agonist of the inwardly rectifying K+ channel Kir2.3, delays the onset of cortical epileptiform activity in a model of chronic temporal lobe epilepsy.
    Neurological research, 2013, Volume: 35, Issue:6

    Topics: Animals; Chronic Disease; Disease Models, Animal; Down-Regulation; Epilepsy, Temporal Lobe; Female; Hippocampus; Indoles; Oxindoles; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Time Factors

2013
Model development and analysis of tenidap-induced proteinuria in the rat.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:3

    Topics: Albumins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bicarbonates; Disease Models, Animal; Dose-Response Relationship, Drug; Electrolytes; Female; Indoles; Kidney; Oxindoles; Proteinuria; Rats; Rats, Sprague-Dawley; Urinalysis

1996
Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity.
    Arthritis and rheumatism, 1997, Volume: 40, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Collagenases; Disease Models, Animal; Dogs; Gelatinases; Gene Expression; Indoles; Interleukin-1; Matrix Metalloproteinase 3; Metalloendopeptidases; Osteoarthritis; Oxindoles; Synovial Fluid; Synovial Membrane

1997
The therapeutic effects of tenidap in canine experimental osteoarthritis: relationship with biochemical markers.
    The Journal of rheumatology, 1997, Volume: 24, Issue:5

    Topics: Animals; Biomarkers; Cartilage; Cyclooxygenase Inhibitors; Disease Models, Animal; Dogs; Gelatinases; Indoles; Interleukin-1; Knee Joint; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Osteoarthritis; Oxindoles; Synovial Membrane

1997
Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis.
    The Journal of rheumatology, 1997, Volume: 24, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Body Weight; Cross-Linking Reagents; Disease Models, Animal; Femur Neck; Flurbiprofen; Indoles; Male; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Oxindoles; Rats; Rats, Inbred Lew; Tetracyclines; Weight-Bearing

1997
Limitation of activity in an acute model of arthritis: effect of drug treatment.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1997, Volume: 46, Issue:12

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Chromatography, High Pressure Liquid; Cricetinae; Disease Models, Animal; Female; Indoles; Indomethacin; Injections, Intra-Articular; Mesocricetus; Motor Activity; Oxindoles; Piroxicam

1997
Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.
    Clinical and experimental immunology, 1998, Volume: 111, Issue:3

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Arthritis, Experimental; Cells, Cultured; Chemokine CCL2; Chemokines; Cyclooxygenase Inhibitors; Disease Models, Animal; Down-Regulation; Gene Expression; Indoles; Interleukin-8; Leukocytes; Oxindoles; Rabbits; RNA, Messenger; Synovial Membrane; Tumor Necrosis Factor-alpha

1998